Canada outperforms 5- and 10-year historic FDI averages in Q4 2022 by: Invest in Canada
As 2022 came to a close, foreign direct investment (FDI) in Canada remained steady with Statistics Canada reporting quarterly net inflows of $17.2 billion in the fourth quarter of 2022, a figure 21.5% higher than the 10-year quarterly and 17% greater than the five-year quarterly average. Total net inflows for the year reached $68.5 billion, the second highest level since 2014.
Major reinvestment from AstraZeneca confirms Canada’s vital role in clinical trials by: Invest in Canada
On February 27, 2023, one day before Rare Disease Day, U.K.-based biopharmaceutical company AstraZeneca and Alexion, its U.S.-based subsidiary focused on rare diseases, announced a $500 million investment in Mississauga, Ontario.
The investment will expand the existing AstraZeneca R&D Hub and also create a new Alexion Development Hub for rare diseases. This major reinvestment in Canada’s life sciences sector is expected to create 500 scientific and high-tech jobs within two years.
FDI 101 – Priority industries for FDI in Canada by: Invest in Canada
FDI 101 – How collaboration propels FDI into Canada by: Invest in Canada
FDI 101 – What is FDI? by: Invest in Canada
2023: Here’s what to expect from Invest in Canada by: Laurel Broten, CEO, Invest in Canada
Steady as she goes: Q3 2022 FDI inflows reach $18.7 billion by: Invest in Canada
FDI is vital to continued aerospace growth in Canada by: Tamaïka Jumelle, Regional Director, Quebec, Invest in Canada
Five questions for Laurel Broten, Invest in Canada’s new Chief Executive Officer by: Invest in Canada
Tremendous growth in reinvested earnings: Global companies show long-term faith in Canada by: Invest in Canada
Umicore chooses Canada for first-of-its-kind EV battery materials plant by: Invest in Canada
